CHI-HU-JIA-LONG-GU-MA-LI-TANG

[Kevinski65]

Has any PCa patient tried this TCM formula? There's been a few studies that say it slows down PCa.

[Tall_Allen]

Post the studies?

[Kevinski65 in reply to Tall_Allen]

It's not science. It's anecdotal. I'm not advocating anyone try it, just wanted to know if anyone might have , on their own, tried it. A great amount of TCM isn't accepted anymore even by the Chinese. They followed over 1000 people somewhere you'd have to Google it. The results may not be accurate. It's probably not appropriate to mention it. There are so many of these concoctions out there, pc-spes is one that comes to mind, Zyflamend is another. I'll look for the article and post it, if I can find it. I doubt, though, it can stand up to the rigors of science.

[pjoshea13]

Kevin,

CHAI-HU-JIA-LONG-GU-MU-LI-TANG?

"Chai-Hu-Jia-Long-Gu-Mu-Li-Tang was the most significant TCM formulae for improving survival in metastatic prostate cancer (aHR 0.18 ..." [1]

From the full text:

"According to the literature, the major components of Chai-Hu-Jia-Long-Gu-Mu-Li-Tang also have anticancer effects. For example, baicalin and baicalein are extracted from Radix Scutellariae, which inhibits prostate cancer growth,[22] induces apoptosis,[23] and reduces free radicals.[24] Saikosaponin-d, extracted from Bupleuri Radix, inhibited human prostate cancer cells by inducing apoptosis and blocking the cell cycle.[25] 6-Shogaol, a component of ginger, restrained the growth of prostate cancer cells both in vitro and in vivo by inhibiting signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) signaling.[26]"

{Scutellaria baicalensis was an ingredient in PC-SPES.}

-Patrick

[1] ncbi.nlm.nih.gov/pubmed/274...

for Full Text: ncbi.nlm.nih.gov/pmc/articl...

Medicine (Baltimore). 2016 Aug;95(31):e4475. doi: 10.1097/MD.0000000000004475.

Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer.

Liu JM1, Lin PH, Hsu RJ, Chang YH, Cheng KC, Pang ST, Lin SK.

Author information

1

aDivision of Urology, Department of Surgery, Taoyuan General Hospital, Ministry of Health and Welfare bDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital cGraduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University dBiobank Management Center of the Tri-Service General Hospital, National Defense Medical Center eDepartment of Pathology and Graduate Institute of Pathology and Parasitology, the Tri-Service General Hospital, National Defense Medical Center fGraduate Institute of Life Sciences, National Defense Medical Center gGraduate Institute of Food Science and Technology, National Taiwan University hInstitute of Biotechnology, National Taiwan University iDepartment of Medical Research, China Medical University Hospital, China Medical University jDepartment of Chinese Medicine, Taipei City Hospital, Renai Branch, Taipei City, Taiwan.

Abstract

More than 50% of prostate cancer patients have used traditional Chinese medicine (TCM) in Taiwan. However, the long-term clinical efficacy of TCM in prostate cancer patients remains unclear. Here, we investigated the relationship between TCM use and the survival of prostate cancer patients.A retrospective nationwide cohort study of prostate cancer patients was conducted between 1998 and 2003 using the Taiwan National Health Insurance Research Database. Patients were classified as TCM users or nonusers, and monitored from the day of prostate cancer diagnosis to death or end of 2012. The association between death risk and TCM use was determined using Cox proportional-hazards models and Kaplan-Meier curves.Of the 1132 selected prostate cancer patients, 730 (64.5%) and 402 (35.5%) were TCM users and nonusers, respectively. The mean follow-up period was 8.38 years, and 292 (25.8%) deaths were reported. TCM users had a decreased mortality rate (21.9%) compared with nonusers (32.8%). A lower death risk was observed with longer TCM use, especially in patients who used TCM for ≧200 days (adjusted hazard ratio [aHR] 0.61, 95% confidence interval [CI] 0.44-0.84). TCM users with metastatic prostate cancer had a significant lower HR than nonusers (aHR 0.70, 95% CI 0.51-0.95). Chai-Hu-Jia-Long-Gu-Mu-Li-Tang was the most significant TCM formulae for improving survival in metastatic prostate cancer (aHR 0.18, 95% CI 0.04-0.94).The result suggested that complementary TCM therapy might be associated with a reduced risk of death in metastatic prostate cancer patients.

PMID: 27495088 PMCID: PMC4979842 DOI: 10.1097/MD.0000000000004475

[Kevinski65 in reply to pjoshea13]

Yes, this is what I read. I know that there are many things that can invalidate a study. I was just curious if anyone had tried it that was active on here. I don't know , they've found that some of these potents have beta sitosterol or some other ingredient that increases estrogen. Some of the ingredients in these formula's may not be safe or could possibly artificially lower PSA readings or increase blood pressure. I wish clinical trials could be done on them or some combination of both allopathic and TCM to see if there are any benefits.

[j-o-h-n]

CHI-HU-JIA-LONG-GU-MA-LI-TANG

Tang is an artificially flavored drink mix that was formulated by General Foods Corporation food scientist William A. Mitchell in 1957, and first marketed in powdered form in 1959. The Tang brand is currently owned by Mondelēz International, a 2012 North American company split off of Kraft Foods Inc.

Sales of Tang were poor until NASA used it on John Glenn's Mercury flight in February 1962, and on subsequent Gemini missions. Since then it has been closely associated with the U.S. manned spaceflight program, and created the misconception that Tang was invented for the space program.

Good Luck, Good Health and Good Humor.

j-o-h-n Thursday 07/25/2019 8:21 PM DST